GSK Cuts 641 Jobs in Vaccine Manufacturing Restructuring
GSK plc (NYSE:GSK) plans to close its vaccine manufacturing facility in Dresden, Germany, by summer 2027, putting 641 jobs at risk.
Glaxosmithkline Plc (GSK)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 35,722,792 | $1,872,588,820 | +4% | 0.56% |
| 2. | Point72 Asset Management Steve Cohen | 2,652,881 | $139,064,022 | 0.15% | |
| 3. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 1,633,029 | $85,603,380 | +1% | 0.04% |
| 4. | D E Shaw D. E. Shaw | 1,019,449 | $53,439,517 | 0.03% | |
| 5. | LMR Partners Ben Levine, Andrew Manuel And Stefan Renold | 980,479 | $51,396,709 | 0.19% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 64,961,641 | $3,405,289,251 | 0.15% | |
| 2. | 48,197,514 | $2,526,513,684 | 1.32% | |
| 3. | 25,182,068 | $1,320,044,006 | 0.78% | |
| 4. | 11,396,249 | $597,391,372 | 0.1% | |
| 5. | 7,657,562 | $401,409,572 | 0.02% |
News See All
GSK’s mRNA Flu Vaccine Shows Promise, But Can It Deliver Late-Stage?
GSK plc (NYSE:GSK) is advancing its experimental seasonal influenza vaccine into late-stage development after encouraging mid-stage results in both younger and older adults.
Can GSK’s Hepatitis B Breakthrough Become a £2 Billion Opportunity?
GSK plc (NYSE:GSK) has reached two important regulatory milestones involving treatments for chronic hepatitis B and rectal cancer.
HUTCHMED Stock (HCM) Rallies Over 15% on a Major Licensing Deal
HUTCHMED stock soared on Thursday after the company announced a new licensing deal with GlaxoSmithKline.
Inside ARMH, STHH and ASMH: Three Semiconductor ADRhedged™ ETFs, and What the Currency Hedge Actually Added
The ASML Holding NV ADRhedged™ (ASMH) carries a TipRanks Smart Score of 10 out of 10, the top of the scale, alongside a Strong Buy analyst consensu...
Could GSK plc (GSK)’s Pipeline Acceleration Unlock a New Growth Era?
On July 28, GSK plc (NYSE:GSK) reported its second-quarter financial results, delivering strong core operational performance and showcasing steady commercial momentum.
GSK plc (GSK) Launches Tender Offer to Acquire Nuvalent Inc. for $124 Per Share
We recently compiled a list of the 12 Best Low-Priced Pharma Stocks to Buy Right Now. GSK plc (NYSE:GSK) is one of the best low-priced pharma stocks on this list.
12 Best Low-Priced Pharma Stocks to Buy Right Now
In this article, we will be taking a look at the 12 Best Low-Priced Pharma Stocks to Buy Right Now.
Is GSK plc (GSK) Expanding Its Anti-Infectives Leadership With New FDA-Approved Therapy?
We recently compiled a list of the 10 Best Weight Loss Drug Stocks to Buy in 2026. GSK plc (NYSE:GSK) is one of the best weight loss drugs on this list.
10 Best Weight Loss Drug Stocks to Buy in 2026
In this article, we will be taking a look at the 10 Best Weight Loss Drug Stocks to Buy in 2026. The anti-obesity drug (AOM) market in the United States is rapidly changing structurally.
Hedge Fund Resource Center